Imad Tabbara is an Oncology physician. OpenAlex indexes 76 publications with 3,376 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2150 Pennsylvania Ave NW
Washington, DC 200373201
Telephone
202-741-2222Registry record last updated 8 Jul 2007.
Industry payments
57 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BeOne Medicines USA, Inc.Program year202515 payments$18,873openpaymentsdata.cms.gov ↗
- BeiGene USA, Inc.Program year20258 payments$11,963openpaymentsdata.cms.gov ↗
- Geron CorporationProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
67.5%RANK Ligand Inhibitor65.3%Denosumab100%Part B, office-administered≥12 patientsXanthine oxidase inhibitor2.3%Allopurinol100%Part D<11 patientsCancer & immunology
9.9%Kinase inhibitor4.6%Brukinsa63%Imbruvica20%Sprycel17%Part D<11 patientsThalidomide Analog2.4%Revlimid53%Pomalyst47%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
5.9%Corticosteroid3%Prednisone100%Part D≥17 patientsSerotonin-3 Receptor Antagonist1.6%Ondansetron Odt60%Ondansetron Hcl41%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”